Addus Homecare (NASDAQ:ADUS) posted its earnings results on Tuesday. The company reported $0.48 EPS for the quarter, topping the Zacks’ consensus estimate of $0.40 by $0.08, Fidelity Earnings reports. The business had revenue of $137.63 million during the quarter, compared to analyst estimates of $139.43 million. Addus Homecare had a return on equity of 10.45% and a net margin of 3.43%.
NASDAQ ADUS opened at $69.67 on Wednesday. The firm has a market cap of $835.33 million, a P/E ratio of 48.05, a P/E/G ratio of 2.65 and a beta of -0.26. The company has a current ratio of 3.09, a quick ratio of 3.09 and a debt-to-equity ratio of 0.53. Addus Homecare has a fifty-two week low of $30.95 and a fifty-two week high of $72.55.
In related news, major shareholder Eos Capital Partners Iii L. P sold 1,024,733 shares of Addus Homecare stock in a transaction on Monday, August 20th. The stock was sold at an average price of $59.00, for a total transaction of $60,459,247.00. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 34.80% of the stock is currently owned by insiders.
Several institutional investors have recently made changes to their positions in ADUS. SG Americas Securities LLC purchased a new position in shares of Addus Homecare in the second quarter valued at about $118,000. Paloma Partners Management Co purchased a new position in shares of Addus Homecare in the second quarter valued at about $201,000. Dorsey & Whitney Trust CO LLC purchased a new position in shares of Addus Homecare in the third quarter valued at about $212,000. State Board of Administration of Florida Retirement System purchased a new position in shares of Addus Homecare in the third quarter valued at about $220,000. Finally, Hartford Investment Management Co. purchased a new position in shares of Addus Homecare in the second quarter valued at about $275,000. Institutional investors and hedge funds own 82.42% of the company’s stock.
Several analysts recently commented on ADUS shares. BidaskClub lowered Addus Homecare from a “strong-buy” rating to a “buy” rating in a report on Tuesday, July 10th. Stephens lifted their price objective on Addus Homecare from $67.00 to $75.00 and gave the stock an “overweight” rating in a report on Tuesday, August 7th. Robert W. Baird reaffirmed a “hold” rating and issued a $65.00 price objective on shares of Addus Homecare in a report on Wednesday, August 8th. Oppenheimer lifted their target price on Addus Homecare from $50.00 to $72.00 and gave the company an “outperform” rating in a research report on Wednesday, August 8th. Finally, Zacks Investment Research downgraded Addus Homecare from a “hold” rating to a “strong sell” rating in a research report on Monday, August 13th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the company. Addus Homecare currently has a consensus rating of “Buy” and a consensus price target of $72.50.
About Addus Homecare
Addus HomeCare Corporation provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company's personal care services offer assistance with activities of daily living. Its services include assistance with bathing, grooming, oral care, assistance with feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services, as well as other activities of daily living.
Featured Article: Tariff
Receive News & Ratings for Addus Homecare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus Homecare and related companies with MarketBeat.com's FREE daily email newsletter.